Detalhe da pesquisa
1.
Management of type 1 gastric neuroendocrine tumors: an 11-year retrospective single-center study.
BMC Gastroenterol
; 23(1): 440, 2023 Dec 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38097952
2.
A Ki-67 Index to Predict Treatment Response to the Capecitabine/Temozolomide Regimen in Neuroendocrine Neoplasms: A Retrospective Multicenter Study.
Neuroendocrinology
; 111(8): 752-763, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-32668427
3.
Circulating miRNA-202-3p is a potential novel biomarker for diagnosis of type 1 gastric neuroendocrine neoplasms.
BMC Gastroenterol
; 21(1): 188, 2021 Apr 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-33892648
4.
Clinicopathological characteristics and risk factors for recurrence of well-differentiated pancreatic neuroendocrine tumors after radical surgery: a case-control study.
World J Surg Oncol
; 17(1): 66, 2019 Apr 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30975157
5.
[Effect of Shengjiang Xiexin Decoction on the Repair of Damaged Rat Intestinal Mucosa after Irinotecan Chemotherapy].
Zhongguo Zhong Xi Yi Jie He Za Zhi
; 35(10): 1236-43, 2015 Oct.
Artigo
em Zh
| MEDLINE | ID: mdl-26677677
6.
[Treatment of Epidermal Growth Factor Receptor Inhibitors Associated Adverse Skin Reactions by Zhiyang Pingfu Liquid: a Clinical Study].
Zhongguo Zhong Xi Yi Jie He Za Zhi
; 35(7): 820-2, 2015 Jul.
Artigo
em Zh
| MEDLINE | ID: mdl-26380445
7.
Prognostic value of inflammation-related biomarkers in patients with gastroenteropancreatic neuroendocrine neoplasms: A systematic review and meta-analysis.
J Neuroendocrinol
; 36(4): e13381, 2024 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38468159
8.
Effects of sangu decoction on osteoclast activity in a rat model of breast cancer bone metastasis.
Evid Based Complement Alternat Med
; 2012: 381904, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-23243441
9.
Advances in medical treatment for pancreatic neuroendocrine neoplasms.
World J Gastroenterol
; 28(20): 2163-2175, 2022 May 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35721885
10.
S-1 plus temozolomide as second-line treatment for neuroendocrine carcinoma of the breast: A case report.
World J Clin Cases
; 9(24): 7146-7153, 2021 Aug 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34540971
11.
Clinicopathological characteristics and prognosis of 232 patients with poorly differentiated gastric neuroendocrine neoplasms.
World J Gastroenterol
; 27(21): 2895-2909, 2021 Jun 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34135560
12.
Clinicopathological characteristics and prognosis of 77 cases with type 3 gastric neuroendocrine tumours.
World J Gastrointest Oncol
; 12(12): 1416-1427, 2020 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33362912
13.
Clinicopathological features and prognostic validity of the European Neuroendocrine Tumor Society (ENETS) and American Joint Committee on Cancer (AJCC) 8th staging systems in colonic neuroendocrine neoplasms.
Cancer Med
; 8(11): 5000-5011, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31293053
14.
Hsa-miR-202-3p, up-regulated in type 1 gastric neuroendocrine neoplasms, may target DUSP1.
World J Gastroenterol
; 24(5): 573-582, 2018 Feb 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29434446
15.
[Taxol based chemotherapy in the treatment of advanced gastric cancer].
Zhonghua Zhong Liu Za Zhi
; 26(9): 562-4, 2004 Sep.
Artigo
em Zh
| MEDLINE | ID: mdl-15555290